Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials.

Erpeldinger S, Rehman MB, Berkhout C, Pigache C, Zerbib Y, Regnault F, Guérin E, Supper I, Cornu C, Kassaï B, Gueyffier F, Boussageon R.

BMC Endocr Disord. 2016 Jul 8;16(1):39. doi: 10.1186/s12902-016-0120-z.

2.

Cardiovascular effects of anti-diabetes drugs.

Younk LM, Lamos EM, Davis SN.

Expert Opin Drug Saf. 2016 Sep;15(9):1239-57. doi: 10.1080/14740338.2016.1195368. Epub 2016 Jun 27. Review.

3.

Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005-2011.

Pathak RD, Schroeder EB, Seaquist ER, Zeng C, Lafata JE, Thomas A, Desai J, Waitzfelder B, Nichols GA, Lawrence JM, Karter AJ, Steiner JF, Segal J, O'Connor PJ; SUPREME-DM Study Group.

Diabetes Care. 2016 Mar;39(3):363-70. doi: 10.2337/dc15-0858. Epub 2015 Dec 17. Erratum in: Diabetes Care. 2017 Aug 25;:.

4.

Impact of insulin treatment in diabetic macular edema therapy in type 2 diabetes.

Matsuda S, Tam T, Singh RP, Kaiser PK, Petkovsek D, Zanella MT, Ehlers JP.

Can J Diabetes. 2015 Feb;39(1):73-7. doi: 10.1016/j.jcjd.2014.06.005. Epub 2014 Oct 22.

5.

Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy.

Jiang T, Yu JT, Zhu XC, Wang HF, Tan MS, Cao L, Zhang QQ, Gao L, Shi JQ, Zhang YD, Tan L.

Br J Pharmacol. 2014 Jul;171(13):3146-57. doi: 10.1111/bph.12655.

6.

Are concomitant treatments confounding factors in randomized controlled trials on intensive blood-glucose control in type 2 diabetes? a systematic review.

Boussageon R, Supper I, Erpeldinger S, Cucherat M, Bejan-Angoulvant T, Kassai B, Cornu C, Gueyffier F.

BMC Med Res Methodol. 2013 Aug 30;13:107. doi: 10.1186/1471-2288-13-107. Review.

7.

Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials.

Boussageon R, Supper I, Bejan-Angoulvant T, Kellou N, Cucherat M, Boissel JP, Kassai B, Moreau A, Gueyffier F, Cornu C.

PLoS Med. 2012;9(4):e1001204. doi: 10.1371/journal.pmed.1001204. Epub 2012 Apr 10.

8.

Cellular dysfunction in diabetes as maladaptive response to mitochondrial oxidative stress.

Naudi A, Jove M, Ayala V, Cassanye A, Serrano J, Gonzalo H, Boada J, Prat J, Portero-Otin M, Pamplona R.

Exp Diabetes Res. 2012;2012:696215. doi: 10.1155/2012/696215. Epub 2012 Jan 2. Review.

9.

Stickiness of the blues: Chronicity of depression.

Swaminath G.

Indian J Psychiatry. 2009 Apr;51(2):82-4. doi: 10.4103/0019-5545.49445. No abstract available.

10.

A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease.

Fisman EZ, Tenenbaum A.

Cardiovasc Diabetol. 2009 Jul 20;8:38. doi: 10.1186/1475-2840-8-38. Review.

11.

Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes.

Richter B, Bandeira-Echtler E, Bergerhoff K, Lerch C.

Vasc Health Risk Manag. 2008;4(4):753-68. Review.

12.

Mass spectrometric quantification of amino acid oxidation products identifies oxidative mechanisms of diabetic end-organ damage.

Vivekanadan-Giri A, Wang JH, Byun J, Pennathur S.

Rev Endocr Metab Disord. 2008 Dec;9(4):275-87. doi: 10.1007/s11154-008-9093-1. Review.

13.

Metformin's contraindications: needed for now.

Fantus IG.

CMAJ. 2005 Aug 30;173(5):505-7. No abstract available.

14.

GLP-1: target for a new class of antidiabetic agents?

Edwards CM.

J R Soc Med. 2004 Jun;97(6):270-4. No abstract available.

15.

A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease.

Pennathur S, Wagner JD, Leeuwenburgh C, Litwak KN, Heinecke JW.

J Clin Invest. 2001 Apr;107(7):853-60.

16.

Should depression be managed as a chronic disease?

Andrews G.

BMJ. 2001 Feb 17;322(7283):419-21. No abstract available.

17.

A survey of diabetes care in general practice in England and Wales.

Pierce M, Agarwal G, Ridout D.

Br J Gen Pract. 2000 Jul;50(456):542-5.

18.

Does social medicine still matter in an era of molecular medicine?

Eisenberg L.

J Urban Health. 1999 Jun;76(2):164-75.

19.
20.

Treating type 2 diabetes. Study was conducted in exemplary fashion.

Narayan KM, Beckles GL, Gregg EW, Williamson DF, Saaddine J, Engelgau MM, Vinicor F.

BMJ. 1999 Mar 6;318(7184):666-7; author reply 668. No abstract available.

Supplemental Content

Support Center